Cargando…

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists

Toll-like receptor (TLR) agonists activate both the innate and the adaptive immune systems. These TLR agonists have been exploited as potent vaccine adjuvants and antitumor agents. We describe the identification and characterization of a small molecule, N-methyl-4-nitro-2-(4-(4-(trifluoromethyl)phen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Kui, Gao, Meng, Godfroy, James I., Brown, Peter N., Kastelowitz, Noah, Yin, Hang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474499/ https://www.ncbi.nlm.nih.gov/pubmed/26101787 http://dx.doi.org/10.1126/sciadv.1400139

Ejemplares similares

TLR1/2 Specific Small‐Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes
por: Cen, Xiaohong, et al.
Publicado: (2019)

TLR1/TLR2 Heterodimers Play an Important Role in the Recognition of Borrelia Spirochetes
por: Oosting, Marije, et al.
Publicado: (2011)

Induction of TLR4/TLR2 Interaction and Heterodimer Formation by Low Endotoxic Atypical LPS
por: Francisco, Sara, et al.
Publicado: (2022)

BacSp222 bacteriocin as a novel ligand for TLR2/TLR6 heterodimer
por: Śmiałek-Bartyzel, Justyna, et al.
Publicado: (2023)

Identification of full length bovine TLR1 and functional characterization of lipopeptide recognition by bovine TLR2/1 heterodimer
por: Farhat, Katja, et al.
Publicado: (2010)

Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
por: Lacerte, Patricia, et al.
Publicado: (2016)

A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation
por: Marshall, Jason D., et al.
Publicado: (2016)

Small-molecule inhibition of TLR8 through stabilization of its resting state
por: Zhang, Shuting, et al.
Publicado: (2017)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Innate Immune Receptors in Human Airway Smooth Muscle Cells: Activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 Agonists
por: Månsson Kvarnhammar, Anne, et al.
Publicado: (2013)

Recent Advances on Small-Molecule Antagonists Targeting TLR7
por: Zheng, Haoyang, et al.
Publicado: (2023)

TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines
por: Israely, Tomer, et al.
Publicado: (2014)

Cytokine Effect of TLR3, TLR4, and TLR7 Agonists Alone or Associated with Leishmania infantum Antigen on Blood from Dogs
por: Martínez-Orellana, Pamela, et al.
Publicado: (2018)

Differential Response of Gestational Tissues to TLR3 Viral Priming Prior to Exposure to Bacterial TLR2 and TLR2/6 Agonists
por: Rasheed, Zahirrah B. M., et al.
Publicado: (2020)

Development of a novel TLR8 agonist for cancer immunotherapy
por: Wang, Yuxun, et al.
Publicado: (2020)

The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013)

Development of N-Acetylated Dipalmitoyl-S-Glyceryl Cysteine Analogs as Efficient TLR2/TLR6 Agonists
por: Zhou, Yang, et al.
Publicado: (2019)

Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8
por: Wang, Xiaoyu, et al.
Publicado: (2022)

Inhibition of IL-12 heterodimers impairs TLR9-mediated prevention of early mouse plasmacytoma cell growth
por: Mandour, Mohamed F., et al.
Publicado: (2023)

Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease
por: Yu, Xiaocong, et al.
Publicado: (2013)

Trial watch: TLR3 agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

OMV Vaccines and the Role of TLR Agonists in Immune Response
por: Mancini, Francesca, et al.
Publicado: (2020)

Formulated Phospholipids as Non-Canonical TLR4 Agonists
por: Liang, Hong, et al.
Publicado: (2022)

TLR Agonist Therapy of Metastatic Breast Cancer in Mice
por: Klinman, Dennis M., et al.
Publicado: (2023)

TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism
por: Noack, J, et al.
Publicado: (2012)

Chronic Exposure of Gingival Fibroblasts to TLR2 or TLR4 Agonist Inhibits Osteoclastogenesis but Does Not Affect Osteogenesis
por: Karlis, Gerasimos D., et al.
Publicado: (2020)

The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
por: Naushad, Shaik Mohammad, et al.
Publicado: (2023)

Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity
por: Beesu, Mallesh, et al.
Publicado: (2015)

Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro
por: Heuking, Simon, et al.
Publicado: (2013)

Pharmacological Activation of p53 during Human Monocyte to Macrophage Differentiation Attenuates Their Pro-Inflammatory Activation by TLR4, TLR7 and TLR8 Agonists
por: Namgaladze, Dmitry, et al.
Publicado: (2021)

Correction to: Development of a novel TLR8 agonist for cancer immunotherapy
por: Wang, Yuxun, et al.
Publicado: (2021)

Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
por: Chuang, Jiin-Haur, et al.
Publicado: (2011)

RO 90-7501 Enhances TLR3 and RLR Agonist Induced Antiviral Response
por: Guo, Fang, et al.
Publicado: (2012)

HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation
por: Henrick, Bethany M., et al.
Publicado: (2015)

Targeting the innate immune receptor TLR8 using small-molecule agents
por: Sakaniwa, Kentaro, et al.
Publicado: (2020)

Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
por: Romerio, Alessio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_atdkhlf0ll9eppse145kts0i36